 |
|
|
|
 |
- A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
Kramer, Kim, MD
[Protocol 03-133]
- A Phase I/II Study of Temsirolimus (CCI-779) in Children with Relapsed or Refractory Solid Tumors (Part 2)
Dunkel, Ira, MD
[Protocol 07-060]
- A Phase II Study of Conformal Radiotherapy in Patients with Low-Grade Gliomas
Dunkel, Ira, MD
[Protocol 07-049]
- A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
Kramer, Kim, MD
[Protocol 05-122]
- A Phase II Study of Motexafin-Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood
Dunkel, Ira, MD
[Protocol 07-140]
- A Phase II Study of Pemetrexed in Children with Recurrent Malignancies
Trippett, Tanya, MD
[Protocol 07-179]
- A Phase III Study Assessing Carboplatin and/or Isotretinoin plus Radiation in Patients with Supratentorial Primitive Neuroectodermal Tumor or High-Risk Medulloblastoma
Gilheeney, Stephen, MD
[Protocol 07-174]
- A Phase III Study of Intensive Induction Chemotherapy with or without Methotrexate Followed by Consolidation Therapy with Stem Cell Rescue in Young Children Newly Diagnosed with Supratentorial PNET or High-Risk Medulloblastoma
Gilheeney, Stephen, MD
[Protocol 07-170]
- GLIOGENE: Genetic Epidemiology of Glioma International Consortium
Bernstein, Jonine, PhD
[Protocol 07-137]
- Phase II Study of Nimotuzumab (TheraCIM®) in Pediatric Patients with Recurrent Diffuse Intrinsic Pontine Glioma
Trippett, Tanya, MD
[Protocol 08-034]
- Radioimmunotherapy, Reduced-Dose External Beam Craniospinal Radiation Therapy with IMRT Boost & Chemotherapy for Patients with Standard-Risk Medulloblastoma
Dunkel, Ira, MD
[Protocol 02-088]
Last Updated: Jan. 23, 2006
|
|
|
|
|
